Edgewise Therapeutics Inc
General ticker "EWTX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.9B
Edgewise Therapeutics Inc follows the US Stock Market performance with the rate: 57.4%.
Estimated limits based on current volatility of 4.1%: low 29.63$, high 32.14$
Factors to consider:
- Current price 239.5% above estimated high
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [5.07$, 10.53$]
- 2023-12-31 to 2024-12-30 estimated range: [4.10$, 8.83$]
Short-term EWTX quotes
Long-term EWTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $43.22MM | $22.08MM | $114.36MM |
| Operating Income | $-43.22MM | $-22.08MM | $-114.36MM |
| Non-Operating Income | $0.80MM | $2.66MM | $14.19MM |
| R&D Expense | $32.19MM | $16.61MM | $90.91MM |
| Income(Loss) | $-42.41MM | $-19.41MM | $-100.16MM |
| Taxes | $0.00MM | $-4.02MM | $0.00MM |
| Profit(Loss) | $-42.41MM | $-15.40MM | $-100.16MM |
| Stockholders Equity | $274.38MM | $346.72MM | $318.83MM |
| Assets | $285.23MM | $367.10MM | $340.04MM |
| Operating Cash Flow | $-33.51MM | $-52.63MM | $-91.95MM |
| Capital expenditure | $0.67MM | $5.55MM | $5.75MM |
| Investing Cash Flow | $-242.23MM | $-70.58MM | $102.89MM |
| Financing Cash Flow | $186.38MM | $129.64MM | $53.17MM |
| Earnings Per Share* | $-0.85 | $-0.29 | $-1.57 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.